1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 | Next

Letter Items 1 - 5 of 77

AHA Comments on CMS Proposed Changes to 340B Drug Discount Program

December 23, 2008

The AHA strongly opposes any approach that would pay hospitals differentially based on their participation in the 340B program. The program was created specifically to help safety-net hospitals and to improve access to care for the poor and uninsured. The program requires drug manufacturers who agreed to participate in the Medicaid Drug Rebate Program to provide deep discounts for drugs and biologics to qualified public and non-profit disproportionate share hospitals and other covered entities that serve these vulnerable populations. Learn More

Comments from the HQA on the OPPS and ASC Final Rule for CY2009

December 19, 2008

Letter to CMS regarding the Outpatient PPS and Ambulatory Surgical Center final rule for CY2009. Learn More

Congress Urges President-elect Obama to Include Hospital Issues in Economic Recovery Package

December 15, 2008

Representatives Robert Brady \(D-PA\) and Joe Wilson \(R-SC\) are asking their House colleagues to sign a letter that urges President-elect Obama to include relief for hospitals in his economic recovery plan. Learn More

AHA to National Medical Association on Reducing Disparities and Opening Opportunities to Minorities

November 25, 2008

AHA is pleased to join with the NMA and AMA in seeking to reduce health disparities and open opportunities for racial and ethnic minorities to become health care professionals. Learn More

Senate Letter to the Department of Defense Re: Transition of the Proposed Rule for TRICARE

November 21, 2008

Senate Letter to the Department of Defence Re: Transition of the Proposed Rule for TRICARE Learn More

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 | Next

About AHA


Member Constituency Sections

Key Relationships

News Center

Performance Improvement

Advocacy Issues

Products & Services


Research & Trends


155 N. Wacker Dr.
Chicago, Illinois 60606

800 10th Street, N.W.
Two CityCenter, Suite 400
Washington, DC 20001-4956